Related Experiment Videos
[Systolic heart failure in the elderly]
1Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar. kilter@med-in.uni-sb.de
Deutsche Medizinische Wochenschrift (1946)
|March 19, 2005
Summary
Aging hearts experience increased vascular stiffness, raising blood pressure and heart workload. Standard heart failure medications are effective in older adults but require careful dosing and monitoring due to age-related physiological changes.
Area of Science:
- Cardiovascular Physiology
- Gerontology
- Pharmacology
Context:
- Aging alters cardiac and vascular structures, increasing heart failure risk.
- Increased vascular stiffness elevates systolic pressure and pulse wave velocity, augmenting cardiac afterload.
- Age-associated sympathetic nervous system changes resemble those in congestive heart failure.
Purpose:
- To review the impact of aging on cardiac and vascular function.
- To discuss the implications for heart failure development and treatment in the elderly.
- To outline therapeutic strategies for systolic heart failure in older populations.
Summary:
- Aging leads to vascular stiffening, increased systolic pressure, and cardiac hypertrophy.
- Molecular changes in the aging sympathetic nervous system mirror those in heart failure.
- Standard heart failure therapies, including ACE inhibitors, beta-blockers, and aldosterone antagonists, are indicated for elderly patients.
Impact:
- Highlights the need for individualized treatment initiation, dosage adjustment, and close monitoring in elderly patients.
- Emphasizes that effective heart failure management in the elderly relies on established pharmacological interventions.
- Underscores the importance of considering comorbidities and altered pharmacokinetics/pharmacodynamics in geriatric cardiovascular care.